Is Sartorius Stedim Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sartorius Stedim Biotech pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 2nd of April 2024 were paid $0.742 per share. Over the last 9 times between 2014 and 2024, Sartorius Stedim Biotech has paid $10.85 with an average of $1.21 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sartorius Stedim Biotech 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $145.38, you would have made a profit of $32.62 per share or 22.44%
No, the average daily trading liquidity for Sartorius Stedim Biotech is $676 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Sartorius Stedim Biotech has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.28, the company's ability to pay off the debt is normal. Sartorius Stedim Biotech has a good net profit margin of 6.17% and should have high tolerances against inflation.
We have calculated the inflation risk for Sartorius Stedim Biotech to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.